Summary of Imaging in 2020: Visualizing the Future of Healthcare with MR Imaging

Brooke A Corbin; Alyssa C Pollard; Matthew J Allen; Mark D Pagel

doi:10.1007/s11307-019-01315-8

Summary of Imaging in 2020: Visualizing the Future of Healthcare with MR Imaging

Mol Imaging Biol. 2019 Apr;21(2):193-199. doi: 10.1007/s11307-019-01315-8.

Authors

Brooke A Corbin¹, Alyssa C Pollard^{2

3}, Matthew J Allen⁴, Mark D Pagel^{5

6}

Affiliations

¹ Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, MI, USA.
² Department of Chemistry, Rice University, 6100 S Main Street, Houston, TX, USA.
³ Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, TX, USA.
⁴ Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, MI, USA. mallen@chem.wayne.edu.
⁵ Department of Chemistry, Rice University, 6100 S Main Street, Houston, TX, USA. mdpagel@mdanderson.org.
⁶ Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, TX, USA. mdpagel@mdanderson.org.

Abstract

The Imaging in 2020 meeting convenes biannually to discuss innovations in medical imaging. The 2018 meeting, titled "Visualizing the Future of Healthcare with MR Imaging," sought to encourage discussions of the future goals of MRI research, feature important discoveries, and foster scientific discourse between scientists from a variety of fields of expertise. Here, we highlight presented research and resulting discussions of the meeting.

Keywords: CEST; Contrast agent; Gadolinium; Imaging; MRI; PET–MRI.

Publication types

Congress
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Contrast Media / chemistry
Delivery of Health Care / trends*
Gadolinium / chemistry
Humans
Magnetic Resonance Imaging*
Molecular Probes / chemistry

Substances

Contrast Media
Molecular Probes
Gadolinium

Abstract

Publication types

MeSH terms

Substances

Grants and funding